PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER

Clinical trials for PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER trials appear

Sign up with your email to follow new studies for PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Two-Pronged attack tested for tough cancers

Disease control Terminated

This study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…

Matched conditions: PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER

Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER

Get alerted when new PLATINUM-SENSITIVE UROTHELIAL BLADDER CANCER trials appear

Two-Pronged attack tested for tough cancers